Old Web
English
Sign In
Acemap
>
Paper
>
CDK12 inhibition enhances sensitivity of HER2+ breast cancers to HER2-TKI via suppressing PI3K/AKT
CDK12 inhibition enhances sensitivity of HER2+ breast cancers to HER2-TKI via suppressing PI3K/AKT
2020
Hui Li
Jinsong Wang
Zongbi Yi
Chunxiao Li
Haijuan Wang
Jingyao Zhang
Ting Wang
Peng Nan
Feng Lin
Dongkui Xu
Qimin Zhan
Haili Qian
Fei Ma
Keywords:
Protein kinase B
PI3K/AKT/mTOR pathway
Cancer research
CDK12
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]